---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-22-019800"
form_type: "8-K"
ticker: "PBYI"
cik: "0001401667"
company_name: "PUMA BIOTECHNOLOGY, INC."
filed_at: "2022-08-10T23:59:59+00:00"
generated_at: "2026-06-24T01:22:36.486481+00:00"
event_type: "litigation"
sentiment: "negative"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Puma Biotechnology retracts defamatory statements about Dr. Frederic Eshelman after court ruling

## Summary
- Retracts 2016 investor-presentation statements implying Dr. Eshelman was fired from PPD and involved in clinical fraud.
- Fourth Circuit affirmed liability verdict on June 23, 2021, but vacated excessive damages award.
- Company states no portion of presentation should be interpreted to suggest Eshelman fired or implicated in fraud.

## SEC filing metadata
- accession: 0001437749-22-019800
- form_type: 8-K
- ticker: PBYI
- cik: 0001401667
- company_name: PUMA BIOTECHNOLOGY, INC.
- filed_at: 2022-08-10T23:59:59+00:00
- event_type: litigation
- sentiment: negative
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1401667/000143774922019800/0001437749-22-019800-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1401667/000143774922019800/pbyi20220810_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-22-019800
- JSON: https://secwatch.observer/filing/0001437749-22-019800.json
- Plain text: https://secwatch.observer/filing/0001437749-22-019800.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.